potential treatment of COVID-19
Oryx Biotech to invest $300mn at Summit Technopolis for bio plant
Oryx Biotech, a subsidiary of Oryx Biotech Holdings based in China, signed a tripartite agreement with Summit Technopolis and BHTPA for a biotech investment worth USD 300 million in Bangladesh.
4 years ago